Discounted Cash Flow Rating

Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Buy

A

Sensei Biotherapeutics, Inc. Common Stock (SNSE)

Pharmaceutical Preparations

https://www.senseibio.com

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. The company currently has three investigational products. 1) SNS-101 is a conditionally active monoclonal antibody targeting the immune checkpoint VISTA (V-domain Ig suppressor of T-cell activation): 2) SNS-102 is a conditionally active monoclonal antibody targeting VSIG4 (V-Set and Immunoglobulin Domain Containing 4), an immune checkpoint often expressed on macrophages: 3) SNS-103 is a conditionally active monoclonal antibody targeting ENTPDase1 (ecto-nucleoside triphosphate diphosphohydrolase-1), also known as CD39.

1405 RESEARCH BLVD, SUITE 125
ROCKVILLE, MD

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/04/2021

Market Cap

15,319,535

Shares Outstanding

25,000,000

Weighted SO

24,996,517

Total Employees

N/A

Upcoming Earnings

08/01/2024

Beta

0.0260

Last Div

0.0000

Range

0.51-1.94

Chg

0.0001

Avg Vol

114959

Mkt Cap

15319535

Exch

NASDAQ

Country

US

Phone

240 243 8000

DCF Diff

0.3657

DCF

0.2434

Div Yield

0.0000

P/S

5.3828

EV Multiple

-0.2649

P/FV

0.2930

Div Yield %

0.0000

P/E

-0.5153

PEG

-0.0221

Payout

0.0000

Current Ratio

10.9000

Quick Ratio

10.9000

Cash Ratio

2.4027

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

696.9722

CCC

-696.9722

Gross Margin

0.6971

Op Margin

-11.3830

Pretax Margin

-10.4259

Net Margin

-10.4259

Eff Tax Rate

-0.0411

ROA

-0.4962

ROE

-0.4814

ROCE

-0.5906

NI/EBT

1.0000

EBT/EBIT

0.9159

EBIT/Rev

-11.3830

Debt Ratio

0.0844

D/E

0.0967

LT Debt/Cap

0.0473

Total Debt/Cap

0.0882

Int Coverage

-476.4118

CF/Debt

-4.8022

Equity Multi

1.1458

Rec Turnover

0.0000

Pay Turnover

0.5237

Inv Turnover

0.0000

FA Turnover

0.4934

Asset Turnover

0.0476

OCF/Share

-0.9652

FCF/Share

-0.9711

Cash/Share

2.0829

OCF/Sales

-8.5144

FCF/OCF

1.0060

CF Coverage

-4.8022

ST Coverage

-9.8705

CapEx Coverage

-165.9726

Div&CapEx Cov

-165.9726

P/BV

0.2930

P/B

0.2930

P/S

5.3828

P/E

-0.5153

P/FCF

-0.6284

P/OCF

-0.6310

P/CF

-0.6310

PEG

-0.0221

P/S

5.3828

EV Multiple

-0.2649

P/FV

0.2930

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation